Novo’s development chief, Martin Holst Lange, has shown optimism about the drug’s promise, though he refrained from making any guarantees.
As Race To Best ‘Miracle’ Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
